Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Amedisys Inc (AMED) just unveiled an announcement.
The Oregon Health Authority has initiated a detailed review of UnitedHealth Group’s proposed acquisition of Amedisys, with the process expected to take up to 180 days from December 4, 2023. Approval from the OHA is a critical requirement for the transaction to proceed, highlighting the significant regulatory scrutiny such healthcare market deals undergo. This development is a key consideration for stakeholders and investors watching the evolving landscape of the healthcare industry.
See more insights into AMED stock on TipRanks’ Stock Analysis page.